In this presentation CEO, Peter Zerhouni presents highlights from Q3 report and CMO Thomas Knittel deep dives into previous clinical results on cobitolimod.

Watch the full video on our youtube channel: https://www.youtube.com/c/HCAndersenCapital

HC Andersen Capital receives payment from InDex Pharmaceuticals through a Digital IR/Corporate Visibility agreement.